Connection
Clay Burlew to Heparin
This is a "connection" page, showing publications Clay Burlew has written about Heparin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.368 |
|
|
|
-
Stettler GR, Sumislawski JJ, Debot M, Moore EE, Burlew CC. Low-Dose Heparin Infusion as Venous Thromboembolism Chemoprophylaxis in Patients With Blunt Cerebrovascular Injury. J Surg Res. 2023 06; 286:1-7.
Score: 0.181
-
Swayngim R, Preslaski C, Burlew CC, Beyer J. Comparison of clinical outcomes using activated partial thromboplastin time versus antifactor-Xa for monitoring therapeutic unfractionated heparin: A systematic review and meta-analysis. Thromb Res. 2021 Dec; 208:18-25.
Score: 0.166
-
Jones TS, Burlew CC, Kornblith LZ, Biffl WL, Partrick DA, Johnson JL, Barnett CC, Bensard DD, Moore EE. Blunt cerebrovascular injuries in the child. Am J Surg. 2012 Jul; 204(1):7-10.
Score: 0.021